The PRIME-TB project aims to establish four knowledge hubs that can pilot and scale up successful innovations in TB case detection and models of care, and conduct enhanced molecular and epidemiological surveillance, supporting the micro-elimination of TB in these areas.

Through the mSupply open project, open source software will be made available for installation that will facilitate medical product registration and stock management of medical products across health system levels.

Through a scholarship program, national regulatory authority staff will complete postgraduate level courses from the Graduate Certificate in Health Products Regulation program at Duke-National University of Singapore.

The national drug quality laboratories of Cambodia and Laos will be strengthened to international laboratory standards with the necessary capacity and functionality to conduct drug quality testing.

Australia’s Therapeutic Goods Administration is working with key Indo-Pacific counterparts to improve their regulatory systems and processes, including through sharing regulatory information.

The Innovative Vector Control Consortium (IVCC) develops new insecticides for vector control by focusing resources and targeting practical scientific solutions.

Medicines for Malaria Venture (MMV) is recognized as the leading product development partnership in the field of antimalarial drug research and development.

FIND, the global alliance for diagnostics, is an international non-profit organization that enables the development and delivery of much-needed diagnostic tests for poverty-related diseases.

The Watershed Interventions for Systems Health in Fiji (WISH Fiji) project seeks to optimise water, sanitation and catchment management, improve outbreak response and minimise the impact of water-borne diseases.

TB Alliance is a not-for-profit product development partnership (PDP) committed to R&D that is urgently needed for better tuberculosis treatments.